HDAC3 and peripheral neuropathy: Since HDAC3 inhibition and HDAC2 activation by Theophylline treatment act through different pathways, it would be interesting to test whether a combination treatment could have additive or synergistic effects in the induction of (re)myelination and functional recovery in demyelinating peripheral neuropathies.